AppLovin Is Cheaper Than Ever, And Nobody's Buying It

Here's the thing about AppLovin that keeps traders up at night: the fundamentals stopped being the problem six months ago, and the market knows it. That doesn't make the stock a buy. It makes it a war.

Let's set the scene. APP closed Monday around $269, down roughly 60% year-to-date and near its 52-week low of $260.59. The S&P has been chugging along. AppLovin has been falling off a cliff. Beta of 2.56 — this isn't a stock, it's a lever with no off switch.

Now look at what's actually happening inside the company, because the tape and the balance sheet are living in two different universes.

Q2 2026 revenue hit $1.92 billion, up about 52% year-over-year. Net income of $1.27 billion. Free cash flow of $863 million. Adjusted EBITDA margin near 84%. For three quarters running this has been a money-printing machine dressed in ad-tech clothes. And yet the stock is near the bottom of its range, and it closed Monday up a modest 1.12% — as if relief were off the table.

So why the carnage?

Because on August 5, management slipped. Revenue missed by a razor-thin margin against consensus — $1.92 billion versus $1.94 billion — and in the same breath admitted the "pace of meaningful model improvement was lighter than normal." For a company priced on expectation, not earnings, that was the trigger. The stock fell nearly 20% in a day. The generative AI video creative tool they'd promised was "still a work in progress." Management later called creative tools "the biggest hurdle" for their e-commerce push.

That single wobble cracked the whole thesis, and the Street got nervous enough to start editing the future. Analysts carved targets down in a wave: Piper Sandler to $385, Wells Fargo to $357, Jefferies to $375, BofA to $325. Short-sellers came sniffing — one report tied the company to a money laundering syndicate (stock dropped ~17%), competition allegations took another ~8%. The company disputes all of it. The SEC closed its inquiry with no recommended action. None of it stopped the selling.

Here's where I have a view, and it's the reason this is interesting rather than just tragic.

At ~$269, AppLovin trades at roughly 15x forward earnings — below peer Magnite despite being vastly larger. The Street's own consensus price target sits around $478, implying roughly 77% upside. UBS's Karl Keirstead has a $790 target. That's not a whisper of conviction; that's the analysts who own this stock telling you they still believe in it. Twenty-seven of 33 rate it Buy or Strong Buy. Zero Sell ratings.

So we have a company with 84% EBITDA margins, printing cash, trading at a forward multiple that would make a hardware stock blush, with analysts sitting on their hands waiting for the price to catch up. And still down 60%.

The problem is the margin for error. That's the phrase analysts started using after August. AppLovin no longer gets to be wrong. Model improvements have to be meaningful, every quarter, on schedule. The creative tool gap is a real execution risk, not a press-release problem. And the numbers keep getting trimmed — over the prior 30 days, 2027 EPS estimates went down more than they went up.

Which brings me to the calendar, because that's where the trade actually lives now.

October 23: A court hearing on the Unity dispute — records, sealing, the procedural stuff. AppLovin sued Unity over data from MAX-mediated auctions, opened JAMS arbitration for breach of contract and trade-secret misappropriation. It's not a headline nuke yet, but it's a live one.

November 4: The Q3 earnings release. This is the real test. Guidance points to $2.055–$2.085 billion in revenue at roughly 83% EBITDA margin, but guidance is exactly what this market stopped believing in August.

November 11: A Q3 guidance update.

November 16: The lead-plaintiff deadline on the securities class action. That's a date, not a catalyst — it's lawyers clocking in, not a re-rating.

My read? This isn't a value trap and it isn't a free lunch. It's a coin flip with leverage, and the coin is weighted by execution.

If Q3 lands — strong start, the CEO says it's off to a good one, consumer advertiser spend finished 28% above Q4 2025 levels — the multiple re-expands violently. Downside is somewhat floored by the cash, the margins, and the fact that 33 analysts already priced in the disappointment. But AppLovin doesn't get credit for being cheap while it's falling. It gets punished for being wrong.

So here's the honest version: buy it if you can stomach a 2.56 beta and you believe the creative-tool gap closes before the next earnings. The market has already handed you a 77%-upside option on a company making nearly 65% profit margins. Sell-side consensus agrees with you. The only thing standing between you and being right is the company actually delivering.

And in this stock, that's the only thing that's ever mattered.